Delivery Order SPE2DB22D3016-SPE2DB25FBKK1
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets (30-count) with a ceiling value of $1,510.60. This non-set-aside, competitively awarded contract reflects a firm fixed price delivery order with an ultimate completion date of September 9, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor for military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $11,040.23 to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets (30-count units) on September 25, 2025, with completion expected by September 26, 2025. The contract employs firm fixed price pricing and represents a non-set-aside competitive award. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a leading...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,566.78 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count packages) under a firm fixed-price contract type. This delivery order, issued on August 22, 2025, with an ultimate completion date of August 25, 2025, represents a non-competitive procurement executed without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Rexulti 1 mg tablets (30-count units) with a ceiling value of $18,866.61. This non-set-aside contract award reflects a firm fixed price delivery order with an ultimate completion date of August 8, 2025. The contract is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,809.99 on September 16, 2025, for the supply of Rexulti 1 mg tablets (30-count package). This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by September 17, 2025. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the pharmaceutical distributor maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $18,016.09 to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets (30-count packages) under a firm fixed-price contract. This non-set-aside delivery order, awarded on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a routine pharmaceutical procurement fulfilling military healthcare supply requirements. The products will be delivered from the vendor's location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $31,550.03 to AmerisourceBergen Drug Corp for the supply of Rexulti 0.5 mg tablets (30-count) under contract number 4569070004. This non-competitive delivery order, awarded on August 12, 2025, with an ultimate completion date of August 13, 2025, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Rexulti 1 mg tablets (30-count units) valued at $5,136.24. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the pharmaceutical distributor's corporate office location in Conshohocken, Pennsylvania. The contract is scheduled for completion by August 7, 2025, and represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, valued at $18,081.18, for 30-count tablets of Rexulti 1 mg on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a single transaction under the company's broader pharmaceutical supply relationship with the federal government. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a Delivery Order valued at $2,783.93 to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets (30-count) on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The order represents a single transaction under AmerisourceBergen Drug Corp's larger...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBKK1Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,494.83 to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets (30-count package), with a completion date of September 22, 2025. This is a firm fixed price delivery order issued under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, PA. This delivery order is executed as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime IDV serves as a comprehensive pharmaceutical support vehicle enabling AmerisourceBergen to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains, supporting customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.5k | 9/19/25 |